Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 1;26(2):e172-e180.
doi: 10.4317/medoral.24101.

Oral health effects of botulinum toxin treatment for drooling: a systematic review

L-B Corrêa  1 , M-B Basso, B Sousa-Pinto, S Coelho Leal
Affiliations

Oral health effects of botulinum toxin treatment for drooling: a systematic review

L-B Corrêa et al. Med Oral Patol Oral Cir Bucal. .

Abstract

Background: Drooling is a major morbidity in several neurological diseases. Intraglandular botulinum neurotoxin (BoNT) injections have been used to manage this condition. However, by decreasing salivary flow, BoNT injections may result in an increased risk of caries and other oral adverse effects. In this study, we aimed to assess whether, in patients with drooling, intraglandular BoNT injections are associated with increased dental caries development, modifications on salivary composition (oral pH, buffering capacity and osmolality) and cariogenic bacterial load.

Material and methods: We performed a systematic review, searching PubMed, CENTRAL, Web of Science, and Scopus for all experimental and observational studies reporting on adverse effects of intraglandular BoNT injections in patients with drooling. Primary study selection, quality assessment, and data extraction were independently performed by two researchers. No studies were excluded based on their language, publication status or date of publication. Studies' quality was based on revised Cochrane Risk of Bias tools. Meta-analysis was not performed.

Results: We retrieved 1025 studies, of which 5 were included. Two studies were two randomized controlled trials and three quasi-experimental studies. None of the included studies found BoNT injections to be associated with dental caries development or with significant reductions in oral pH. One of the included primary studies even observed an increase in salivary buffer capacity. One study found an increase in Lactobacilli counts. As for the risk of bias, two studies were classified as having a critical risk, two as high risk and one as having some concerns.

Conclusions: Currently, there is no evidence that, in patients with drooling, BoNT injections associate with increased risk of dental caries or disturbances in oral pH or salivary buffering capacity. However, the included primary studies had important limitations and differences in their methodologies.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest The authors declared no conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1
Figure 1
PRISMA flow diagram.
Figure 2
Figure 2
Risk of bias for randomized studies (by robvis tool).
Figure 3
Figure 3
Risk of bias for non-randomized studies for saliva composition and caries (by robvis tool).
Figure 4
Figure 4
Risk of bias for non-randomized studies for cariogenic bacteria counts (by robvis tool).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Morgante F, Bavikatte G, Anwar F, Mohamed B. The burden of sialorrhoea in chronic neurological conditions: current treatment options and the role of incobotulinumtoxinA (Xeomin®) Ther Adv Neurol Disord. 2019;12:1–21. - PMC - PubMed
    1. Isaacson SH, Ondo W, Jackson CE, Trosch RM, Molho E, Pagan F. Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults. JAMA Neurol. 2020;77:E1–9. - PMC - PubMed
    1. Varley LP, Denieffe S, O'Gorman C, Murphy A, Gooney M. A systematic review of noninvasive and invasive sialorrhoea management. J Clin Nurs. 2019;28:4190–206. - PubMed
    1. Abboud WA, Nadel S, Hassin-Baer S, Arad A, Dobriyan A, Yahalom R. Ultrasound-Guided Botulinum Toxin Injections into the Salivary Glands for the Treatment of Drooling. Isr Med Assoc J. 2019;2:116–9. - PubMed
    1. Taib BG, Williams SP, Sood S, Ung K, Nixon PP, Sharma R. Treatment of sialorrhoea with repeated ultrasound-guided injections of botulinum toxin A into the parotid and submandibular glands. Br J Oral Maxillofac Surg. 2019;57:442–8. - PubMed

Publication types

Substances